Literature DB >> 8014585

Effects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy male subjects.

W C Duane1.   

Abstract

We measured bile acid kinetics and bile lipids in 12 human subjects on a metabolic ward in four randomly allocated, 6-7 week periods: 1) lovastatin (40 mg b.i.d) + low cholesterol diet (mean 246 mg/day); 2) lovastatin+high cholesterol diet (mean 1071 mg/day); 3) low cholesterol diet alone; and 4) high cholesterol diet alone. Lovastatin did not significantly alter fractional turnover, synthesis, absorption, enterohepatic cycling, or pool sizes of bile acid measured by the Lindstedt method. The high cholesterol diet increased fractional turnover and synthesis rate of cholic acid, but not chenodeoxycholic acid, without altering pool size of either bile acid. The high cholesterol diet decreased bile acid absorption, but only during lovastatin treatment, suggesting the possibility of a "cholestyramine-like" effect of dietary cholesterol, appreciable at least when biliary cholesterol secretion is reduced by lovastatin. As in previous studies, lovastatin markedly lowered saturation index of gallbladder bile. Increased cholesterol consumption did not significantly alter cholesterol saturation index, suggesting that dietary cholesterol may not be a major factor in cholesterol gallstone pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014585

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation.

Authors:  N M Fisher; K Meksawan; A Limprasertkul; P J Isackson; D R Pendergast; G D Vladutiu
Journal:  J Inherit Metab Dis       Date:  2007-04-05       Impact factor: 4.982

2.  Lipoprotein cholesterol uptake mediates up-regulation of bile-acid synthesis by increasing cholesterol 7alpha-hydroxylase but not sterol 27-hydroxylase gene expression in cultured rat hepatocytes.

Authors:  S M Post; J Twisk; L van der Fits; E C de Wit; M F Hoekman; W H Mager; H M Princen
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 3.  Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

Authors:  Helen H Wang; Piero Portincasa; Ornella de Bari; Kristina J Liu; Gabriella Garruti; Brent A Neuschwander-Tetri; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-02-19       Impact factor: 4.686

4.  Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.

Authors:  Zidong Donna Fu; Julia Yue Cui; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2014-10-02       Impact factor: 5.922

5.  Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice.

Authors:  B Khanuja; Y C Cheah; M Hunt; P M Nishina; D Q Wang; H W Chen; J T Billheimer; M C Carey; B Paigen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

6.  Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.

Authors:  Thomas Sudhop; Michael Reber; Diane Tribble; Aditi Sapre; William Taggart; Patrice Gibbons; Thomas Musliner; Klaus von Bergmann; Dieter Lütjohann
Journal:  J Lipid Res       Date:  2009-04-20       Impact factor: 5.922

7.  A Diet-Sensitive BAF60a-Mediated Pathway Links Hepatic Bile Acid Metabolism to Cholesterol Absorption and Atherosclerosis.

Authors:  Zhuo-Xian Meng; Lin Wang; Lin Chang; Jingxia Sun; Jiangyin Bao; Yaqiang Li; Y Eugene Chen; Jiandie D Lin
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

Review 8.  The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo.

Authors:  Marco Bertolotti; Andrea Crosignani; Marina Del Puppo
Journal:  Molecules       Date:  2012-02-16       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.